Edarbyclor Interactions
There are 516 drugs known to interact with Edarbyclor (azilsartan medoxomil/chlorthalidone), along with 19 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 43 are major, 441 are moderate, and 32 are minor.
- View all 516 medications that may interact with Edarbyclor
- View Edarbyclor alcohol/food interactions (2)
- View Edarbyclor disease interactions (19)
Most frequently checked interactions
View interaction reports for Edarbyclor (azilsartan medoxomil / chlorthalidone) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- Bystolic (nebivolol)
- carvedilol
- clonidine
- CoQ10 (ubiquinone)
- Edarbi (azilsartan medoxomil)
- furosemide
- gabapentin
- hydralazine
- hydrochlorothiazide
- levothyroxine
- losartan
- metformin
- metoprolol
- Myrbetriq (mirabegron)
- nifedipine
- omeprazole
- pantoprazole
- potassium chloride
- prednisone
- rosuvastatin
- spironolactone
- tamsulosin
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Edarbyclor alcohol/food interactions
There are 2 alcohol/food interactions with Edarbyclor (azilsartan medoxomil / chlorthalidone).
Edarbyclor disease interactions
There are 19 disease interactions with Edarbyclor (azilsartan medoxomil / chlorthalidone) which include:
- diabetes
- angioedema
- hypotension
- anuria
- electrolyte losses
- liver disease
- lupus erythematosus
- renal function disorders
- CHF
- hyperkalemia
- renal impairment
- liver disease
- renal impairment
- asthma
- diabetes
- hyperlipidemia
- hyperparathyroidism
- hyperuricemia
- thyroid function tests
Report options
More about Edarbyclor (azilsartan medoxomil / chlorthalidone)
- Edarbyclor consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (24)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: angiotensin II inhibitors with thiazides
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
